Coadministration of liposomal methylglyoxal increases the activity of amphotericin B against Candida albicans in leukopoenic mice

References

• Fidel PL Jr. Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis. Adv Dent Res. 2011;23:45–49.
   PubMedGoogle Scholar
• Giri S, Kindo AJ. A review of Candida species causing blood stream infections. Indian J Med Microbiol. 2012;30:270–278.
   PubMed Web of Science ®Google Scholar
• Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45:305–320.
   PubMed Web of Science ®Google Scholar
• Gazendam RP, van Hamme JL, Tool AT, et. al. Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood. 2014;124:590–597.
   PubMed Web of Science ®Google Scholar
• Khan MA, Khan A, Owais M. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice. FEMS Immunol Med Microbiol. 2006;46:63–69.
   PubMedGoogle Scholar
• Qian Q, Jutila MA, Van Rooijen N, et al. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol. 1994;152:5000–5008.
   PubMed Web of Science ®Google Scholar
• Crowe SM, Vardaxis NJ, Kent SJ, et al. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol. 1994;56:318–327.
   PubMed Web of Science ®Google Scholar
• de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev. 2004;17:729–759.
   PubMed Web of Science ®Google Scholar
• Duppont B. Overview of lipid formulations of amphotericin B. J Antimicrob Chemother. 2002;49:31–36.
   Web of Science ®Google Scholar
• Khan MA, Owais M. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. J Antimicrob Chemother. 2006;58:125–132.
   PubMed Web of Science ®Google Scholar
• Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int. 2013;2013:204237.
   PubMed Web of Science ®Google Scholar
• Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol. 2019;17:141–155.
   PubMed Web of Science ®Google Scholar
• Talukdar D, Ray S, Ray M, et al. A brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patients. Drug Metabol Drug Interact. 2008;23:175–210.
   PubMedGoogle Scholar
• Kilty SJ, Duval M, Chan FT, et al. Methylglyoxal: (active agent of Manuka honey) in vitro activity against bacterial biofilms. Int Forum Allergy Rhinol. 2011;1:348–350.
   PubMed Web of Science ®Google Scholar
• Hayes G, Wright N, Gardner SL, et al. Manuka honey and methylglyoxal increase the sensitivity of Staphylococcus aureus to linezolid. Lett Appl Microbiol. 2018;66:491–495.
   PubMed Web of Science ®Google Scholar
• Oliveira A, Ribeiro HG, Silva AC, et. al. Synergistic antimicrobial interaction between honey and phage against Escherichia coli biofilms. Front Microbiol. 2017;8:2407.
   PubMed Web of Science ®Google Scholar
• Pavlovic-Djuranovic S, Kum JF, Schultz JE, et al. Dihydroxyacetone and methylglyoxal as permeants of the Plasmodium aquaglyceroporin inhibit parasite proliferation. Biochim Biophys Acta. 2006;1758:1012–1017.
   PubMed Web of Science ®Google Scholar
• Khan MA, Nasti TH, Saima K, et. al. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. FEMS Immunol Med Microbiol. 2004;41:249–258.
   PubMed Web of Science ®Google Scholar
• Khan MA, Faisal SM, Mohammad O. Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model. J Drug Target. 2006;14:233–241.
   PubMed Web of Science ®Google Scholar
• Khan MA, Nasti TH, Owais M. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice. J Antimicrob Chemother. 2005;56:726–731.
   PubMed Web of Science ®Google Scholar
• Khan MA, Aljarbou AN, Aldebasi YH, et al. Combination of glycosphingosomes and liposomal doxorubicin shows increased activity against dimethyl-α-benzanthracene-induced fibrosarcoma in mice. Int J Nanomedicine. 2015;10:6331–6338.
   PubMed Web of Science ®Google Scholar
• Pal A, Talukdar D, Roy A, et al. Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect. Int J Nanomedicine. 2015;10:3499–3518.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Talukdar D, Pal A, et al. Immunomodulation of macrophages by methylglyoxal conjugated with chitosan nanoparticles against Sarcoma-180 tumor in mice. Cell Immunol. 2014;287:27–35.
   PubMed Web of Science ®Google Scholar
• Maswadeh HM, Aljarbou AN, Alorainy MS, Alsharidah MS, et al. Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model. Biomed Res Int. 2015;2015:743051.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition; CLSI document M27-A3. Wayne (PA): CLSI; 2008a.
   Google Scholar
• Laskar AA, Khan MA, Rahmani AH, et al. Thymoquinone, an active constituent of Nigella sativa seeds, binds with bilirubin and protects mice from hyperbilirubinemia and cyclophosphamide-induced toxicity. Biochimie. 2016;127:205–213.
   PubMed Web of Science ®Google Scholar
• Alrumaihi F, Allemailem KS, Almatroudi A, et al. Tinospora cordifolia aqueous extract alleviates cyclophosphamide-induced immune suppression, toxicity and systemic candidiasis in immunosuppressed mice: in vivo study in comparison to antifungal drug fluconazole. Curr Pharm Biotechnol. 2019;20:1055–1063.
   PubMed Web of Science ®Google Scholar
• Alsuhaibani S, Khan MA. Immune-stimulatory and therapeutic activity of Tinospora cordifolia: double-edged sword against Salmonellosis. J Immunol Res. 2017;2017:1787803.
   PubMed Web of Science ®Google Scholar
• Afzal RK, Khalid F, Hannan A, et al. Methylglyoxal: antimicrobial activity against blood culture isolates of Salmonella Typhi and other Gram negative rods. Pak J Med Sci. 2019;35:1110–1114.
   PubMed Web of Science ®Google Scholar
• Bulman SEL, Tronci G, Goswami P, et al. Antibacterial properties of nonwoven wound dressings coated with Manuka honey or methylglyoxal. Materials (Basel). 2017;16:10.
   Google Scholar
• Charyasriwong S, Haruyama T, Kobayashi N. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection. Drug Discov Ther. 2016;10:201–210.
   PubMed Web of Science ®Google Scholar
• Jin X, McGrath MS, Xu H. Inhibition of HIV expression and integration in macrophages by methylglyoxal-bis-guanylhydrazone. J Virol. 2015;89:1176–1189.
   Web of Science ®Google Scholar
• Khan MA, Jabeen R, Nasti TH, et al. Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model. J Antimicrob Chemother. 2005;55:223–228.
   PubMed Web of Science ®Google Scholar
• Silva EG, Paula CR, Dias AL, et al. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans. Mycopathologia. 2011;171:261–266.
   PubMed Web of Science ®Google Scholar
• Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin ormicafungin. AAC. 2005;49:4895–4902.
   Google Scholar
• Ashman RB. Protective and pathologic immune responses against Candida albicans infections. Front Biosci. 2008;13:3334–3351.
   PubMedGoogle Scholar
• Jiménez-López C, Lorenz MC. Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages. PLoS Pathog. 2013;9:e1003741.
   PubMed Web of Science ®Google Scholar
• Frohner IE, Bourgeois C, Yatsyk K, et al. Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol Microbiol. 2009;71:240–252.
   PubMed Web of Science ®Google Scholar
• Westman J, Moran G, Mogavero S, et al. Candida albicans hyphal expansion causes phagosomal membrane damage and luminal alkalinization. MBio. 2018;9:9.
   Web of Science ®Google Scholar
• Filler SG, Yeaman MR, Sheppard DC. Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis. 2005;41 Suppl 3:S208–S212.
   PubMed Web of Science ®Google Scholar
• Ohta H, Tanimoto T, Taniai M, et al. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis. In Vivo. 2007;21:25–32.
   PubMed Web of Science ®Google Scholar
• Rocha FAC, Alves AMCV, Rocha MFG, et al. Tumor necrosis factor prevents Candida albicans biofilm formation. Sci Rep. 2017;7:1206.
   PubMed Web of Science ®Google Scholar
• Vonk AG, Netea MG, van Krieken JH, et al. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J Infect Dis. 2006;193:1419–1426.
   PubMed Web of Science ®Google Scholar